Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda

scientific article

Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1045340026
P356DOI10.1186/1472-6890-9-11
P932PMC publication ID2805675
P698PubMed publication ID20003543
P5875ResearchGate publication ID40681408

P50authorClaudio AgostinelliQ57014900
Stefano A PileriQ86426885
Henry WabingaQ112730275
Brunangelo FaliniQ30119395
P2093author name stringPier Paolo Piccaluga
Simona Righi
Lynnette K Tumwine
Cristina Campidelli
Wilson Byarugaba
Emmanuel Othieno
P2860cites workA biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingQ51940347
Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphomaQ53290562
High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomasQ53803726
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arraysQ57000339
A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 casesQ58221430
Antigen retrieval techniques in immunohistochemistry: comparison of different methodsQ61411745
Sex differences in prognosis for children with acute lymphoblastic leukemiaQ74593412
CD30: expression and function in health and diseaseQ77593448
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaQ27824784
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingQ27860529
Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter?Q35974296
Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolutionQ37331424
Burkitt's lymphoma in Uganda: the role of immunohistochemistry in diagnosis.Q38875535
Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infectionQ38875586
B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarrayQ38876372
Long‐term experience with burkitt's lymphoma in ugandaQ38892656
The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniquesQ39598681
The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based studyQ40220381
Blastocysts prepare for the race to be maleQ40811045
Increased cell division as a cause of human cancerQ41202194
Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.Q41474009
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.Q42432005
Molecular diagnosis of Burkitt's lymphomaQ45207362
The malignant lymphomas of Kenya: Morphology, immunophenotype, and frequency of epstein-barr virus in 73 casesQ45760362
R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacyQ46600594
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P921main subjectUgandaQ1036
Hodgkin lymphomaQ209369
immunohistochemistryQ899285
P304page(s)11
P577publication date2009-12-16
P1433published inBMC Clinical PathologyQ15758091
P1476titleImmunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda
P478volume9

Reverse relations

cites work (P2860)
Q36493451Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory
Q47098487Cytokines associated with Burkitt's lymphoma in western Kenya.
Q34637897Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings.
Q64232948Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma: A study based on bioinformatics analysis
Q51218335Large Cell Lymphoma: Correlation of HIV Status and Prognosis with Differentiation Profiles Assessed by Immunophenotyping
Q59350662Mature outcomes and prognostic indices in diffuse large B-cell lymphoma in Malawi: a prospective cohort
Q34726756Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment
Q46233092The challenge of lymphomas in sub-Saharan Africa

Search more.